Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 2 | 2024 | 329 | 0.820 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2023 | 43 | 0.780 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 40 | 0.770 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2021 | 8 | 0.690 |
Why?
|
| Glomerulonephritis | 1 | 2021 | 32 | 0.680 |
Why?
|
| Melanoma | 1 | 2021 | 331 | 0.530 |
Why?
|
| Transplant Recipients | 1 | 2023 | 37 | 0.200 |
Why?
|
| Lead | 1 | 2023 | 44 | 0.200 |
Why?
|
| Frailty | 1 | 2024 | 125 | 0.180 |
Why?
|
| Renal Dialysis | 1 | 2023 | 195 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2023 | 180 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 107 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2021 | 184 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 60 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2021 | 217 | 0.160 |
Why?
|
| Kidney | 2 | 2023 | 455 | 0.160 |
Why?
|
| Hypoxia | 1 | 2020 | 116 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 358 | 0.150 |
Why?
|
| Peritonitis | 1 | 2018 | 43 | 0.140 |
Why?
|
| Hypertension, Renovascular | 1 | 2018 | 6 | 0.140 |
Why?
|
| Captopril | 1 | 2018 | 8 | 0.140 |
Why?
|
| Renal Artery Obstruction | 1 | 2018 | 22 | 0.140 |
Why?
|
| Radionuclide Imaging | 1 | 2018 | 128 | 0.140 |
Why?
|
| Renal Artery | 1 | 2018 | 36 | 0.140 |
Why?
|
| Angioplasty | 1 | 2018 | 51 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 203 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 285 | 0.130 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 280 | 0.110 |
Why?
|
| Stents | 1 | 2018 | 492 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2016 | 529 | 0.100 |
Why?
|
| Humans | 7 | 2024 | 64272 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 629 | 0.080 |
Why?
|
| Macrophages | 1 | 2016 | 1053 | 0.080 |
Why?
|
| Middle Aged | 2 | 2021 | 17923 | 0.060 |
Why?
|
| Male | 2 | 2021 | 30322 | 0.050 |
Why?
|
| Medication Therapy Management | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 3449 | 0.040 |
Why?
|
| Zymosan | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2018 | 13 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 17 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 237 | 0.030 |
Why?
|
| Angiography | 1 | 2018 | 151 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 368 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 143 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2024 | 1301 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 464 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 131 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1105 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 2096 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 348 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 526 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 351 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2177 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 320 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 219 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 5341 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1769 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1365 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 803 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 1223 | 0.020 |
Why?
|
| Female | 3 | 2018 | 33383 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2237 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 20955 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3068 | 0.020 |
Why?
|
| Mice | 1 | 2018 | 10994 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 14663 | 0.010 |
Why?
|